Peterson BA - Search Results

1

Laboratory and clinical studies of biochemical modulation by hydroxyurea.

Schilsky RL, Ratain MJ, Vokes EE, Vogelzang NJ, Anderson J, Peterson BA. Schilsky RL, et al. Among authors: peterson ba. Semin Oncol. 1992 Jun;19(3 Suppl 9):84-9. Semin Oncol. 1992. PMID: 1641659 Review.

2

Dose intensity in the treatment of diffuse large-cell lymphoma.

Anderson JR, Santarelli MT, Peterson B. Anderson JR, et al. J Clin Oncol. 1990 Nov;8(11):1927-8. doi: 10.1200/JCO.1990.8.11.1927. J Clin Oncol. 1990. PMID: 2230883 No abstract available.

3

High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.

Lichtman SM, Petroni G, Schilsky RL, Johnson JL, Perri RT, Niedzwiecki D, Sklar J, Barcos M, Peterson BA. Lichtman SM, et al. Among authors: peterson ba. Leuk Lymphoma. 2001 Nov-Dec;42(6):1255-64. doi: 10.3109/10428190109097750. Leuk Lymphoma. 2001. PMID: 11911406

4

AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B study.

Parker BA, Santarelli M, Green MR, Anderson JR, Cooper MR, Case D Jr, Barcos M, Peterson BA, Gottlieb AJ. Parker BA, et al. Among authors: peterson ba. J Clin Oncol. 1993 Feb;11(2):248-54. doi: 10.1200/JCO.1993.11.2.248. J Clin Oncol. 1993. PMID: 8426201 Clinical Trial.

5

Vindesine in bronchogenic carcinoma: a phase II trial.

Vogelzang NJ, Peterson BA, Kennedy BJ, Vosika GJ, Conroy JA. Vogelzang NJ, et al. Among authors: peterson ba. Am J Clin Oncol. 1982 Feb;5(1):41-4. Am J Clin Oncol. 1982. PMID: 6282107

6

MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.

Glick JH, Young ML, Harrington D, Schilsky RL, Beck T, Neiman R, Fisher RI, Peterson BA, Oken MM. Glick JH, et al. Among authors: peterson ba. J Clin Oncol. 1998 Jan;16(1):19-26. doi: 10.1200/JCO.1998.16.1.19. J Clin Oncol. 1998. PMID: 9440718 Clinical Trial.

7

Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma.

Ozer H, Anderson JR, Peterson BA, Budman DR, Cooper MR, Kennedy BJ, Silver RT, Henderson ES, Duggan DB, Barcos M, et al. Ozer H, et al. Among authors: peterson ba. Med Pediatr Oncol. 1994;22(4):228-35. doi: 10.1002/mpo.2950220403. Med Pediatr Oncol. 1994. PMID: 8107652 Clinical Trial.

8

Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma.

Ozer H, Anderson JR, Peterson BA, Budman DR, Henderson ES, Bloomfield CD, Gottlieb A. Ozer H, et al. Among authors: peterson ba. Invest New Drugs. 1987;5 Suppl:S27-33. doi: 10.1007/BF00207260. Invest New Drugs. 1987. PMID: 3298131 Clinical Trial.

9

5-Azacytidine and renal tubular dysfunction.

Peterson BA, Collins AJ, Vogelzang NJ, Bloomfield CD. Peterson BA, et al. Blood. 1981 Jan;57(1):182-5. Blood. 1981. PMID: 6160887 Free article.

10

Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.

Kirshner JJ, Anderson JR, Parker B, Barcos M, Cooper MR, Burns LJ, Peterson BA, Gottlieb AJ. Kirshner JJ, et al. Among authors: peterson ba. Cancer. 1993 Mar 1;71(5):1852-6. doi: 10.1002/1097-0142(19930301)71:5<1852::aid-cncr2820710523>3.0.co;2-t. Cancer. 1993. PMID: 8448749 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters